ReP USP - Resultado da busca

Artigo de periodico
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial (2018)
Bohula, Erin A.; Scirica, Benjamin M; Inzucchi, Silvio E; Mcguire, Darren K; Keech, Anthony C; Smith, Steven R; Kanevsky, Estella; Murphy, Sabina A; Leiter, Lawrence A; Nicolau, Jose Carlos
Source: Lancet. Unidade: FM
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, OBESIDADE, SOBREPESO, RECEPTORES DE SUBSTÂNCIAS ENDÓGENAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOHULA, Erin A. et al. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet, v. 392, n. 10161, p. 2269-2279, 2018Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(18)32328-6. Acesso em: 04 jun. 2024.
APA
Bohula, E. A., Scirica, B. M., Inzucchi, S. E., Mcguire, D. K., Keech, A. C., Smith, S. R., et al. (2018). Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet, 392( 10161), 2269-2279. doi:10.1016/S0140-6736(18)32328-6
NLM
Bohula EA, Scirica BM, Inzucchi SE, Mcguire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Nicolau JC. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial [Internet]. Lancet. 2018 ; 392( 10161): 2269-2279.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/S0140-6736(18)32328-6
Vancouver
Bohula EA, Scirica BM, Inzucchi SE, Mcguire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Nicolau JC. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial [Internet]. Lancet. 2018 ; 392( 10161): 2269-2279.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1016/S0140-6736(18)32328-6
Artigo de periodico
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial (2017)
Eisen, Alon; Bonaca, Marc P.; Scirica, Benjamin M.; White, Harvey D.; Tendera, Michal; Dellborg, Mikael; Nicolau, Jose C.; Morais, Joao; Fox, Keith A. A.; Bohula, Erin A.; Murphy, Sabina A.; Braunwald, Eugene; Morrow, David A.
Source: Clinical Chemistry. Unidade: FM
Subjects: BIOMARCADOR, TROPONINA, DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EISEN, Alon et al. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, v. 63, n. 1, p. 307-315, 2017Tradução . . Disponível em: https://doi.org/10.1373/clinchem.2016.264788. Acesso em: 04 jun. 2024.
APA
Eisen, A., Bonaca, M. P., Scirica, B. M., White, H. D., Tendera, M., Dellborg, M., et al. (2017). High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, 63( 1), 307-315. doi:10.1373/clinchem.2016.264788
NLM
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1373/clinchem.2016.264788
Vancouver
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1373/clinchem.2016.264788
Artigo de periodico
Ezetimibe added to statin therapy after acute coronary syndromes (2015)
Cannon, Christopher P.; Blazing, Michael A.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer A.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; Ferrari, Gaetano M. De; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin A.; Reist, Craig; Wiviott, Stephen D.; Tershakovec, Andrew M.; Musline, Thomas A.; Braunwald, Eugene; Califf, Robert M.; Marin Neto, José Antonio; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: SÍNDROME CORONARIANA AGUDA, TERAPÊUTICA MÉDICA, COLESTEROL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANNON, Christopher P. et al. Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, v. 372, n. 25, p. 2387-2397, 2015Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1410489. Acesso em: 04 jun. 2024.
APA
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., et al. (2015). Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, 372( 25), 2387-2397. doi:10.1056/NEJMoa1410489
NLM
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1056/NEJMoa1410489
Vancouver
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1056/NEJMoa1410489

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration